Children, Perennial Allergic Rhinitis (PAR), l-t Growth

NCT00641212 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG: Budesonide
DRUG: Placebo

Sponsor

AstraZeneca